Venture Life Group plc (LON:VLG – Get Free Report) insider Daniel Wells purchased 14,760 shares of the stock in a transaction that occurred on Thursday, October 1st. The shares were purchased at an average price of GBX 68 per share, with a total value of £10,036.80.
Daniel Wells also recently made the following trade(s):
- On Wednesday, September 30th, Daniel Wells purchased 38,717 shares of Venture Life Group stock. The stock was purchased at an average cost of GBX 65 per share, for a total transaction of £25,166.05.
Venture Life Group Price Performance
Shares of Venture Life Group stock opened at GBX 69.41 on Friday. Venture Life Group plc has a 12-month low of GBX 52 and a 12-month high of GBX 72. The company’s fifty day simple moving average is GBX 67.38 and its two-hundred day simple moving average is GBX 65.11. The company has a quick ratio of 1.48, a current ratio of 4.71 and a debt-to-equity ratio of 0.82. The firm has a market cap of £83.33 million, a PE ratio of 15.88, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23.
Venture Life Group Company Profile
Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.
Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.
Further Reading
- Five stocks we like better than Venture Life Group
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.
